There have been no material changes from the risk factors disclosed in the Company's 2025 Form 10-K. Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS The following table summarizes the surrenders of our equity securities during the three months ended June 30, 2026: Period Total Number of Shares Purchased(a) Average Price Paid per Share(a) Total Number of Shares Purchased as Part of Publicly Announced Programs(b) Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs(b) Dollars in millions, except per share data April 1 to 30, 2026 59,703 $ 60.09 — $ 5,014 May 1 to 31, 2026 24,915 $ 58.18 — $ 5,014 June 1 to 30, 2026 109,601 $ 55.10 — $ 5,014 Three months ended June 30, 2026 194,219 — (a)Includes shares of common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of awards under our long-term incentive program. (b)In May 2010, the Board of Directors authorized the repurchase of up to $3.0 billion of our common stock. From time to time thereafter, the Board approved additional share repurchase authorizations totaling an amount of $25.0 billion, including the most recent authorization of $3.0 billion in December 2023. The remaining share repurchase capacity under the program was $5.0 billion as of June 30, 2026. Our share repurchase program does not obligate us to repurchase any specific number of shares, does not have a specific expiration date and may be suspended or discontinued at any time.